Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Travera Inc
Ellipses Pharma
Translational Research in Oncology
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
M.D. Anderson Cancer Center